Company Research Report: Idoven

Overview

Company Name:
Idoven

Mission:
Idoven's mission is to harness the power of AI to detect and prevent cardiovascular diseases, ultimately saving lives.

Founded:
November 2018

Founders:

• Manuel Marina Breysse

• José María Lillo Castellano

Key People:

• Manuel Marina Breysse, CEO & Co-Founder

• José María Lillo Castellano, Chief Scientific Officer & Co-Founder

• Iñigo Juantegui, Advisor & Co-Founder

• Roberto Cruz, Chief Technology Officer

• Isabel Sierra, Chief Legal Officer

• Andreas Ferstad, VP Commercial

• Magdalena Gazda, Talent Manager

• Sonia Chibane, People Specialist

• Advisory Board Members & Investors: Prof. Gregory Y. H. Lip, Dr. Pablo García Pavía, Shruti Rajagopalan, Diego Piacentini, Sebastian Gunningham, Seshu Ajjarapu, Scott Barclay, Alessandro Luciano, Michiel Kotting, Pascual Cortés-Monroy E., Paloma Castellano

Headquarters:
Calle Francisco Campos, 22 - PLT BJ, Madrid, 28002, Madrid

Number of Employees:
No information is available

Revenue:
No information is available

Recognition:
Recognized by EU and US institutions, including Horizon 2020, European Innovation Council, and National Academy of Medicine.

Known For:
Idoven is known for developing the world's first cardiology-as-a-service platform powered by artificial intelligence.

Products

Willem™ ECG Analysis Platform

Description:
Willem™ is an AI-powered ECG analysis platform designed to assist clinicians in diagnosing cardiovascular diseases with high accuracy. It integrates seamlessly with different devices for ECG recording and provides comprehensive analysis within minutes.

Key Features:

• AI algorithms trained on a diverse ECG database

• Capable of identifying 22 cardiac patterns & four intervals

• Certified as Medical Device Class IIa (EU MDR)

• Integration with various ECG device types such as ambulatory ECGs, standard resting ECGs, and insertable cardiac monitors

• Device neutral and available via API

Solutions

For MedTech

• Digital Diagnostics:

• Cloud technology and deep neural networks

• Enables rapid and accurate identification of arrhythmias and cardiac patterns

• Integration with Home Monitoring and Electronic Health Record (EHR) systems

For Life Sciences

• Digital Biomarkers:

• Predicts disease risk scores to identify high-risk, undiagnosed patients

• Assists in better patient management and treatment outcomes

Preventative Screening Programs

• Remote Patient Monitoring:

• Continuous and remote ECG monitoring

• Proprietary algorithms and cardiologists analyze data

• Provides comprehensive reports

Recent Developments

July 2024

Idoven acquires NVIDIA DGX systems for AI advancements

• Significant investment to accelerate AI algorithm training and validation

• Enhances computing power for faster, more accurate diagnoses

May 2024

FAITHFUL Consortium:

• Launched to redefine heart failure detection with AI

• Funding of €1.7 million from EIT Health

• Collaboration with 14 international partners and led by Idoven

April 2024

EIT Health funds the FAITHFUL project:

• Heart failure detection project funded with €1.7 million

• Collaboration with AstraZeneca and other organizations

December 2023

AI platform improvements:

• Enhanced arrhythmia detection in Insertable Cardiac Monitors

• Increased detection from 4 to 25 cardiac rhythm patterns

September 2023

Pau Gasol investment:

• Basketball legend Pau Gasol joins Idoven in new investment round

• Investment led by Northzone, with follow-on funding from Insight Partners

Press Release Excerpts:

• Pau Gasol: "Idoven’s AI technology is changing how we measure heart health, making a huge difference."

• Manuel Marina Breysse: "We are taking our AI model Willem to the next level."

Science & Impact

• One of the most diverse ECG databases with 1.25 million ECG hours

• Collaborations with 17 leading EU and US research centers and industry partners

• Contributions to cardiovascular research with 31 publications in top-tier scientific journals.

Key Achievements:

• Development of the MAESTRIA platform for atrial cardiomyopathy diagnosis

• Ongoing studies like ASSIST for heart attack diagnosis and FAITHFUL for heart failure detection

Key Figures

• 1.25 million ECG hours in the database

• 10,200+ patients monitored in clinical trials

• 22 cardiac patterns detected automatically

Partnerships

• Collaborative Research:

• International consortia and partnerships with institutions like Oxford University, Massachusetts General Hospital, and more.

Some Notable Collaborations:

• MAESTRIA Consortium: Largest database for atrial cardiomyopathy

• ASSIST Consortium: Early heart attack diagnosis utilizing AI ECG analysis

Certifications

• ISO 27001, 27017, 27018, 27701

• Spanish National Security Scheme

• GDPR Compliant

• CE Marked - Class IIa (EU MDR)

Contact Information

Website:
[Idoven](https://idoven.ai)

Social Media:

• LinkedIn: [@idoven](https://www.linkedin.com/company/idoven/)

• Twitter: [@idoven](https://twitter.com/idoven)

---

This structured report covers the key aspects of Idoven, its products, recent developments, scientific impact, and partnerships. For more details, visit their [website](https://idoven.ai).